News
The Augurex team brings together leading scientific, clinical, technical and commercial expertise to ensure that our research translates into advanced diagnostics for improved patient outcomes.
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Vancouver, Canada – August 20, 2024 – Augurex Life Sciences Corp. today announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024. Augurex’s poster, titled “Novel...
World Pharma Congress
Date: April 25 Location: Singapore Attend If: You are a pharmaceutical professional seeking to enhance your knowledge, collaborate with peers, and stay abreast of recent advancements in the field. About: Join WPC for a three-day event aimed at facilitating information...
LSX World Congress
Date: April 29-30 Location: London, UK Attend If: You are involved in the pharmaceutical, biotech, healthtech, or medtech industries and are seeking opportunities for partnership, investment, and strategic planning. About: When considering pharmaceutical conferences...
Pharma USA 2024
Date: March 26–27 Location: Pennsylvania Convention Center, Philadelphia Attend If: If you recognize the need for a modernized commercial model that better serves patients’ needs and aligns with the demands of payers, this is one the most awaited pharma marketing...
Beyond Compliance Jan. 16-18, 2024
Source: Qualio Date: January 16-18 Location: Virtual Attend If: You are a pharmaceutical professional seeking to enhance your knowledge and expertise in compliance with regulatory standards. About: The Beyond Compliance virtual event, which Qualio and Qualistery...
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Vancouver, Canada – August 20, 2024 – Augurex Life Sciences Corp. today announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024. Augurex’s poster, titled “Novel...
Veteran life sciences executive Mr. Neil Klompas to assume role of President and CEO
Augurex Life Sciences Corp. Names Healthcare Leader Neil Klompas to Succeed Co-Founder Dr. Norma Biln as President and CEO Veteran life sciences executive Mr. Neil Klompas to assume role of President and CEO Co-Founder and outgoing CEO Dr. Norma Biln to helm research...
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Vancouver, Canada – August 20, 2024 – Augurex Life Sciences Corp. today announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024. Augurex’s poster, titled “Novel...
Augurex Achieves MDSAP Certification
Vancouver, BC – August 22, 2024 – Augurex Life Sciences Corp., a leader in biomarker-driven diagnostic solutions for the detection and management of autoimmune diseases, today announced its successful certification under the Medical Device Single Audit Program...
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Vancouver, Canada – August 20, 2024 – Augurex Life Sciences Corp. today announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024. Augurex’s poster, titled “Novel...
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Vancouver, Canada – August 20, 2024 – Augurex Life Sciences Corp. today announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024. Augurex’s poster, titled “Novel...
Veteran life sciences executive Mr. Neil Klompas to assume role of President and CEO
Augurex Life Sciences Corp. Names Healthcare Leader Neil Klompas to Succeed Co-Founder Dr. Norma Biln as President and CEO Veteran life sciences executive Mr. Neil Klompas to assume role of President and CEO Co-Founder and outgoing CEO Dr. Norma Biln to helm research...
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Vancouver, Canada – August 20, 2024 – Augurex Life Sciences Corp. today announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024. Augurex’s poster, titled “Novel...
World Pharma Congress
Date: April 25 Location: Singapore Attend If: You are a pharmaceutical professional seeking to enhance your knowledge, collaborate with peers, and stay abreast of recent advancements in the field. About: Join WPC for a three-day event aimed at facilitating information...
LSX World Congress
Date: April 29-30 Location: London, UK Attend If: You are involved in the pharmaceutical, biotech, healthtech, or medtech industries and are seeking opportunities for partnership, investment, and strategic planning. About: When considering pharmaceutical conferences...
Pharma USA 2024
Date: March 26–27 Location: Pennsylvania Convention Center, Philadelphia Attend If: If you recognize the need for a modernized commercial model that better serves patients’ needs and aligns with the demands of payers, this is one the most awaited pharma marketing...
Beyond Compliance Jan. 16-18, 2024
Source: Qualio Date: January 16-18 Location: Virtual Attend If: You are a pharmaceutical professional seeking to enhance your knowledge and expertise in compliance with regulatory standards. About: The Beyond Compliance virtual event, which Qualio and Qualistery...
Home
Products
Science
About
News
Careers
Contact